CFO
Ind-Swift Laboratories Limited
Equibles does not estimate personal net worth.
Gagan Agarwal is recorded as CFO at Ind-Swift Laboratories Limited. Gagan Agarwal has spoken on 1 earnings call across 1 company, most recently for Ind-Swift Laboratories Limited on August 17, 2026. Ind-Swift Laboratories Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“The growth story which Mr. Pradeep told, this was for the agreement with Vatrace for two products, mainly ibuprofen and clary granules. And we have just kickstarted this product, this project, and sales for only these two molecules was hardly 5 to 6 crores.”
Ind-Swift Laboratories Limited
CFO
Transcript header (unverified)
Ind-Swift Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call for the Quarter Ended June 30, 2026
Ind-Swift Laboratories Limited
